Dr Carol Tang, Prinicpal Investigator & Head Neuro-Oncology Research Laboratory, National Neuroscience Institute & Dr Christopher Ang, Consultant, Department of Neurosurgery, National Neuroscience Institute; Clinical Investigator,S'pore Institute for Clinical Sciences
The BMRC-NMRC Joint Grant Call for research proposals is now open!
This collaborative effort between BMRC and NMRC serves to create synergy among the basic researchers and clinician scientists.
Applications to A*STAR can be made electronically at the A*STAR website: (http://bmrcgrants.a-star.edu.sg). An original application (hard copy) endorsed by the Host Institution and a soft copy (Word format) must be submitted to BMRC, A*STAR through the Host Institution’s research office following the electronic submission. Principal Investigators may approach their respective Research Offices should they have difficulty accessing the online system. Projects that are related to stem cells may be funded by the Singapore Stem Cell Consortium.
For applications to NMRC, the application forms can be downloaded from NMRC website (www.nmrc.gov.sg). An original application (hard copy) endorsed by the Host Institution and a soft copy (Word format) must be submitted to NMRC through the Host Institution's research office.
Please note that applications for funding of case control and cohort studies will be capped at $1 million over 3 years. The hypotheses to be tested for these studies should be achievable within the 3 year funding period.
German developmental biologists say they have found a simpler recipe for creating safer stem cells to be used on people with genetic diseases.The new method of creating induced pluripotent stem cells, called iPS cells, makes the technology safer for clinical treatments by making it less likely the cells could cause complications such as cancer, the researchers write in this week's issue of ...
Dr. Jiong Jiong Wang, Ph.D., Assistant Professor of Radiology and Neurology (Research Track), Center for Functional Neuroimaging Departments of Radiology and Neurology, Hospital of the University of Pennsylvania
Professor Marilyn Telen, Professor and Chief, Division of Haematology, Duke University Medical Centre Director, Duke-UNC Comprehensive Sickle Cell Centre, Co-Director of the Duke Hospital Transfusion Service
Dr John D Potter, Fred Hutchinson Cancer Research Center, University of Washington, School of Public Health & Community Medicine, USA Cancer Research UK, Cambridge Research Institute, Cambridge, England
Kah-Leong LIM Senior Research Scientist and Head, Neurodegeneration Research Lab, National Neuroscience Institute; Assistant Professor, Duke-NUS Graduate Medical School; Assistant Professor, NUS Department of Biological Sciences
Professor Steven R Tannenbaum , Underwood-Prescott Professor of Toxicology, Department of Biological Engineering; Professor of Chemistry, Department of Chemistry, Massachusetts Institute of Technology, USA
Dr. Mariapia A DEGLI-ESPOSTI, Centre for Experimental Immunology, Lions Eye Institute and Immunology and Virology Program, Centre for Ophthalmology and Visual Sciences, The University of Western Australia, Perth, Western Australia
10 Feb 2009
Centre for Life Sciences Level 1, Auditorium @ CeLS Building, NUS
San Jose Mercury News Wed, 18 Feb 2009 WASHINGTON - At the National Institutes of Health, officials have started drafting guidelines they will need to start funding human embryonic stem cell research that has been off-limits for nearly eight years...
Laser, Skin and Wellness clinic in Melbourne Chadstone will discuss non-surgical face surgery & botox alternatives using Skeyndor MesoScience Virtual MesoTherapy on Feb 19 and Feb 26, 2009 at the Laser clinic in Chadstone Shopping Centre in Melbourne Your Skin's Re-Birth Open House...
In May 2001, Israeli parents of a nine-year old boy with a crippling disease that left him wheelchair-bound took their child to see doctors in Moscow. In a highly experimental procedure that was presumably unavailable in their home country, those doctors injected embryonic stem cells into various regions of his brain...
Fluidigm Corporation announced that Stanford University has used the unique single-cell gene expression capabilities of the company's integrated fluidic circuits (IFCs) to help identify the source of cancer stem cells' resistance to radiation...
A Johns Hopkins engineer is trying to coax human stem cells to turn into networks of new blood vessels that could someday be used to replace damaged tissue in people with heart disease, diabetes and other illnesses...
Scientists are carrying out clinical tests with patients who have suffered from a severe heart attack. With the implantation of the patientâs stem cells, the heart regenerates thus improving its wall motion, that is, its cardiac performance...
WASHINGTON (Reuters) - U.S. researchers said on Thursday they had come up with the safest way yet to make stem-like cells using a patient's ordinary skin cells, this time by using pure human proteins....
CHICAGO (AFP) - The technology for versatile, grow-in-a-dish transplant tissue took a step toward clinical use Thursday when researchers announced they have found a safe way to turn skin cells into stem cells... read more
Prof. Jeffrey W. Pollard, Louis Goldstein Swan Chair in Women’s Cancer Research, Director, Center for the Study of Reproductive Biology and Women’s Health, Albert Einstein College of Medicine, NY, U.S.A.
26 May 2010
3 - 4 pm
CeLS Auditorium, 28 Medical Drive, Level 1, Centre for Life Sciences
Recent cancer and stem cell research has shown that cells called tumor-initiating cells, or TICs, have the ability to self-renew and proliferate within tumor masses to maintain the tumor. This finding contributed to a new theory, coined the cancer stem cell (CSC) hypothesis, which proposed clonogenic growth and self-renewal potential being restricted to a subset of cells within tumors - tumor ...
A suffering pet gets stem-cell breakthrough surgery By dawn house The Salt Lake Tribune Updated Sep 17, 2010 09:16PM MDT Holladay Honey, a 9-year-old Labrador retriever, utilizing stem cells from her own body, underwent a first-ever procedure for Utah that is expected to heal the dogs hip dysplasia. The procedure, performed Friday at Cottonwood Animal Hospital, involved removing fatty tissue ...
Metabolic Solutions Development Company (MSDC), will present research at the European Association for the Study of Diabetes (EASD) annual conference in Stockholm, Sweden on Sept. 23, 2010. The research indicates that the company's clinical candidate, MSDC-0160, promotes the proliferation of stem cells that create brown fat, leading to the creation of more brown fat. The research was conducted in ...
Prof Wolf-Herman Fridman Natural and modulated tumor microenvironment influences survival in Prof Paola Castagnoli, INSERM U872, Université Paris-Descartes, Cordeliers Research Centre, Université Pierre et Marie Curie
24 Jan 2010
11 am - 12 pm
SIgN Seminar Room, Immunos Building Level 4, Biopolis